Evident Corporation

Evident Corporation, formerly the scientific imaging division of Olympus Corporation which was spun out in 2022, is a global leader in optical microscopy and imaging systems for life science research, clinical diagnostics, and industrial inspection. The company's IX and BX series inverted and upright research microscopes are among the most widely deployed platforms in academic and pharmaceutical labs, valued for their optical quality, modular expandability, and extensive accessory ecosystem. Evident's FluoView series confocal laser scanning microscopes provide high-resolution three-dimensional fluorescence imaging for cell biology, developmental biology, and neuroscience research. Their TIRF (Total Internal Reflection Fluorescence) microscopy systems enable single-molecule imaging and surface-proximal fluorescence detection. The Slideview VS200 and VS120 slide scanning systems automate high-throughput whole-slide imaging for pathology, high-content screening, and digital pathology workflows. Evident's super-resolution microscopes based on structured illumination microscopy (STED-inspired IX83 configurations) push beyond the diffraction limit for subcellular structure imaging. Their cellSens imaging software provides integrated acquisition, analysis, and data management for complex multidimensional imaging experiments. In industrial science, Evident manufactures ultrasonic flaw detectors, eddy current inspection instruments, and video borescopes for non-destructive testing. Their OmniScan phased array ultrasonic testing systems are used in aerospace and pipeline inspection where material integrity characterization overlaps with applied physics research.